This funding record is inactive. Please see the program website or contact the program sponsor to determine if this program is currently accepting applications or will open again in the future.

Integrated Human Immunodeficiency Virus (HIV) Surveillance and Prevention Programs for Health Departments

Link

https://www.cdc.gov/hiv/funding/announcements/ps18-1802/index.html

Additional Links

Notice of Funding Opportunity (Grants.gov)

Deadline

Letter of Intent (Optional): Jul 11, 2017
Application Deadline: Sep 13, 2017

Sponsoring Organization

Centers for Disease Control and Prevention (CDC)

Purpose

Funds state health departments' efforts to develop and implement comprehensive and integrated HIV surveillance and prevention programs. Programs will improve data and understanding of HIV infection and transmission in order to guide more targeted prevention strategies in geographic areas highly affected by HIV and among high risk populations, such as people who inject drugs (PWID). Applicants may request funding under two program components. Component A funds all core program activities. Component B is optional and provides funding for demonstration projects.

Component A core strategies and activities include:

  • Systematically collect, analyze, interpret, and disseminate HIV data to accurately characterize HIV trends, detect active HIV transmission, and inform health policy
  • Identify people with HIV and at risk for HIV infection by implementing HIV testing programs, providing partner services, and conducting data-to-care (D2C) activities
  • Develop, maintain, and implement a plan to rapidly respond to HIV transmission clusters and outbreaks
  • Provide HIV-related prevention services for people living with HIV infection, especially through the promotion and monitoring of antiretroviral therapy (ART)
  • Provide HIV-related prevention services for HIV-negative people by providing HIV testing and increasing access to pre-exposure prophylaxis (PrEP)
  • Conduct perinatal prevention and surveillance activities by promoting routine perinatal HIV testing for all pregnant women
  • Conduct community-level prevention activities through social marketing and media, and community mobilizations, including syringe services and condom distribution programs
  • Develop partnerships for HIV prevention and care planning by establishing an HIV planning group (HPG) and engaging local stakeholders
  • Implement structural strategies to strengthen HIV-related health policies and protocols and health information systems infrastructure
  • Conduct data-driven monitoring and evaluation to continuously improve program activities
  • Build capacity for conducting effective HIV program activities, epidemiological science, and geocoding

Component B funds allow grantees to enhance their programs by adding a demonstration project. Demonstration projects are innovative, high-impact approaches to HIV surveillance or prevention that would not normally fall under Component A requirements.

Fact sheet

Amount of Funding

Component A estimated awards: Core program funding ranges
Component A project period: 5 years
Component A estimated number of awards: 61

Component B estimated awards: Demonstration projects:

  • $1,000,000 to $2,000,000 for 2 awards
  • $500,000 to $1,000,000 for 6 awards
  • Up to $500,000 for 12 awards
Component B project period: 4 years
Component B estimated number of awards: 20

Estimated total program funding: $2,000,000,000

Who Can Apply

Applications may be submitted by state, local, and territorial health departments or their bona fide agents currently funded under the Comprehensive Human Immunodeficiency Virus (HIV) Prevention Programs for Health Department (PS12-1201) or the National HIV Surveillance System (NHSS) (PS13-1302).

Eligible jurisdictions include:

  • All 50 states
  • District of Columbia
  • Puerto Rico
  • Virgin Islands
  • Northern Mariana Islands
  • American Samoa
  • Guam
  • Federated States of Micronesia
  • Marshall Islands
  • Palau

Local or city health departments serving the following metro areas are also eligible:

  • City of Baltimore
  • City of Chicago
  • Fulton and DeKalb counties, Georgia
  • City of Houston and Harris county, Texas
  • Los Angeles County, California
  • Philadelphia county, Pennsylvania
  • Bronx, Kings, New York, Queens, and Richmond counties, New York
  • San Francisco county, California

Geographic Coverage

Nationwide

What This Program Funds

Equipment • New Program • Operating Costs and Staffing

Application Process

Application instructions and other information about the online application process are available on the program website.

Applicant frequently asked questions

Applicants may also apply for additional Component B funding for a demonstration project. Demonstration projects are innovative programs, activities, or approaches to HIV surveillance and prevention that are particularly novel or require additional resources. Applicants may only submit one demonstration project proposal.

Contact

For programmatic or technical questions:
Renata D. Ellington
404-639-6030
HDFOA@cdc.gov

For grants management or budget questions:
Constance Jarvit
770-488-5859
ABQ3@cdc.gov

Topics This Program Addresses

Harm Reduction • Health and Wellness • Infectious Diseases • Syringe Services Programs